Bristol Myers Squibb CEO says FDA stability is critical for drug innovation

Fireside Chat with Chris Boerner and Euan Ashley | Stanford Medicine's AI in Life Sciences Symposium

Bristol Myers Squibb CEO: Richest product pipeline we've had in the last decade

Bristol Myers CEO on Biontech deal: Next new frontier in treatment of cancer

Pharma exec won't commit to selling life-saving drug in U.S. for lower price offered in Canada

Bristol Myers Squibb | Global Patient Week 2023: LinkedIn Live

Bristol-Myers CEO Says the Company Is in Transition